학술논문
Cyclophosphamide as a first-line therapy in LGL leukemia.
Document Type
Article
Author
Source
Subject
*CYCLOPHOSPHAMIDE
*LYMPHOCYTES
*METHOTREXATE
*ALTERNATIVE medicine
*LEUKEMIA treatment
*
*
*
*
Language
ISSN
0887-6924
Abstract
The article presents a study on the effectiveness of cyclophosphamide as a first-line therapy in large granular lymphocyte (LGL) leukemia which could be an interesting alternative to methotrexate. It reveals that cyclophosphamide should be given to patients for at least 4 months before changing drug regimen. It also notes that cyclophosphamide is effective in T/NK-LGL leukemia, in both neutropenic and anemic patients, based on a series of study conducted.